AbstractThe emergence of carbapenem resistance in Pseudomonas aeruginosa threatens the efficacy of this important anti-pseudomonal antibiotic class. Between 2003 and 2006, an increase in the number of carbapenem-resistant P. aeruginosa isolates at the Zonguldak Karaelmas University Hospital was observed (Zongul-dak, Turkey). To assess the imipenem resistance mechanisms emerging in these P. aeruginosa isolates, they were characterized by amplified fragment length polymorphism typing, which revealed diversity among imipenem-resistant isolates as well as two clonally related outbreak groups. The molecular mechanism of carbapenem resistance was characterized in a representative isolate from each clonal group. Mutational disruption of oprD was t...
ABSTRACTMultidrug-resistant isolates of a clonal lineage of Pseudomonas aeruginosa producing the VIM...
Background: ESBL- and carbapenemase-producing Pseudomonas aeruginosa are prevalent in, for example, ...
International audienceWe investigated the presence of carbapenemases in carbapenem-resistant Pseudom...
AbstractThe emergence of carbapenem resistance in Pseudomonas aeruginosa threatens the efficacy of t...
The emergence of carbapenem resistance in Pseudomonas aeruginosa threatens the efficacy of this impo...
This study explored the evolutionary mechanism by which the clinical isolate PA110514 yields the imi...
Abstract Background Carbapenemase genes are one of th...
Carbapenem (imipenem and meropenem) resistance in Pseudomonas aeruginosa is increasing, with global...
Pseudomonas aeruginosa is opportunistic pathogen, one of the leading causes of nosocomial infections...
Pseudomonas aeruginosa may cause life-threatening infections, especially in nosocomial settings. Alt...
Our study aims to define the epidemiology of carbapenem resistance mechanisms in clinical isolates o...
Pseudomonas aeruginosa (P. aeruginosa) is ubiquitous in nature, and may be a causative agent in seve...
BACKGROUND: Imipenem resistance in Pseudomonas aeruginosa most often entails loss of the 'carbapenem...
Objectives: To investigate the mechanisms of carbapenem resistance in the 175 Pseudomonas aeruginosa...
Resistance to carbapenems is emerging, and it is a great problem to therapeutics. Seven multidrug-re...
ABSTRACTMultidrug-resistant isolates of a clonal lineage of Pseudomonas aeruginosa producing the VIM...
Background: ESBL- and carbapenemase-producing Pseudomonas aeruginosa are prevalent in, for example, ...
International audienceWe investigated the presence of carbapenemases in carbapenem-resistant Pseudom...
AbstractThe emergence of carbapenem resistance in Pseudomonas aeruginosa threatens the efficacy of t...
The emergence of carbapenem resistance in Pseudomonas aeruginosa threatens the efficacy of this impo...
This study explored the evolutionary mechanism by which the clinical isolate PA110514 yields the imi...
Abstract Background Carbapenemase genes are one of th...
Carbapenem (imipenem and meropenem) resistance in Pseudomonas aeruginosa is increasing, with global...
Pseudomonas aeruginosa is opportunistic pathogen, one of the leading causes of nosocomial infections...
Pseudomonas aeruginosa may cause life-threatening infections, especially in nosocomial settings. Alt...
Our study aims to define the epidemiology of carbapenem resistance mechanisms in clinical isolates o...
Pseudomonas aeruginosa (P. aeruginosa) is ubiquitous in nature, and may be a causative agent in seve...
BACKGROUND: Imipenem resistance in Pseudomonas aeruginosa most often entails loss of the 'carbapenem...
Objectives: To investigate the mechanisms of carbapenem resistance in the 175 Pseudomonas aeruginosa...
Resistance to carbapenems is emerging, and it is a great problem to therapeutics. Seven multidrug-re...
ABSTRACTMultidrug-resistant isolates of a clonal lineage of Pseudomonas aeruginosa producing the VIM...
Background: ESBL- and carbapenemase-producing Pseudomonas aeruginosa are prevalent in, for example, ...
International audienceWe investigated the presence of carbapenemases in carbapenem-resistant Pseudom...